跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Lenalid 5
Approved
STANDARD
Lenalid 5
Natco Pharma Limited (Unit IV and V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
75be067ae00f9726
Company
Natco Pharma Limited (Unit IV and V)
Type
Standard
Approval Details
Approval Id
75be067ae00f9726
Drug Approval Philippines Name
Lenalid 5
Product Name
Lenalid 5
Registration Number
DR-XY48671
Brand Name
Lenalid 5
Generic Name
Lenalidomide
Dosage Form
Capsule
Dosage Strength
5 mg
Manufacturer
Natco Pharma Limited (Unit IV and V)
Importer
Natco Lifesciences Philippines, Inc.
Distributor
Natco Lifesciences Philippines, Inc.
Issuance Date
28 March 2023
Expiry Date
28 March 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
75be067ae00f9726
Type
Standard
Back to Philippines FDA Approvals
Lenalid 5 - Philippines FDA Drug Approval Details